Meta AnalysisID 960

大蒜素根除幽门螺杆菌:一项随机对照试验的Meta分析

CRD42019118199

To assess the effects and safety of Allicin on Helicobacter pylori eradication.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
960
Evidence Id
9518
Core Evidence Id
9518
Source Meta Analysis Id
932
Herb2 Meta Analysis Id
HBMA000932
Crd Id
CRD42019118199
Title
Allicin for helicobacter pylori eradication: a meta-analysis of randomized controlled trials
Review Question
To assess the effects and safety of Allicin on Helicobacter pylori eradication.
Study Type Included
Regardless of the length of treatment, we will include all randomised controlled trials that compare H. pylori eradication rate as well as adverse incidence rate between allicin used alone or combined with conventional treatments and conventional treatments in accordance with experiment group.
Condition Being Studied
Helicobacter pylori (H. pylori) is classified as class I carcinogens by the world health organization , and may cause damage to cells, resulting in clinical consequences from asymptomatic gastritis to peptic ulcer and gastric malignancies. Currently, proton-pump inhibitors or bismuth combined with two antibiotics are used to inhibit the secretion of gastric acid, protect gastric mucosa and resist H. pylori.However, it was found in clinical practice that the eradication rate of H. pylori decreased gradually due to the increased resistance of H. pylori to antibiotics such as metronidazole, clarithromycin and levofloxacin. Besides, long-term clinical use of antibiotics will lead to gastrointestinal dysfunction, gastrointestinal flora imbalance and other adverse reactions. Previous studies showed that allicin had good bacteriostatic effect on H. pylori, with a total inhibition rate of 92.2%. A growing number of clinical controlled studies have found that allicin can improve the eradication rate of H. pylori and reduce the incidence of adverse reactions, but there is no systematic review yet. Therefore, on the basis of extensive literature collection, we will conduct a meta-analysis to assess the eradication rate and incidence of adverse reactions of allicin in the treatment of H. pylori eradication.
Participant
The subjects included will be H. pylori infected patients.The diagnostic criteria will be consistent with one or more of the following items showing positive results: rapid urease test (RUT), 13C-ureabreath test(13CBUT), 14C-ureabreath test(14CBUT), or histology.
Animal
Human Disease Modelled
Intervention
The intervention measures in the treatment group will be allicin used alone or combined with conventional treatments.
Comparator Control
The control group will be treated with conventional therapy in accordance with experiment group.
Main Outcome
The primary outcome measure will be eradication rate of H.pylori after treatment, which will be simultaneously confirmed by one or more following items showing negative results: RUT, 13CBUT, 14CBUT, or histology.
Outcome Measure
Additional Outcome
Incidence rate of adverse event.
Study Method
Intervention, Meta-analysis, Systematic review
Keyword
Helicobacter Infections; Helicobacter pylori; Humans; Randomized Controlled Trials as Topic; Sulfinic Acids; allicin
Contact
Xiaotao Jiang [email protected]
Organisational Affiliation
Guangzhou univercity of Chinese Medicine http://www.gzucm.edu.cn/
Funding Source
Funding provided by Fengbin Liu
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2018-12-04
Registration Date
2019-01-04
Anticipated Start Date
2019-01-01
Anticipated Completion Date
2019-08-01
Title Cn
大蒜素根除幽门螺杆菌:一项随机对照试验的Meta分析
Title En
Allicin for helicobacter pylori eradication: a meta-analysis of randomized controlled trials
Bilingual Status
complete